Biocryst Pharmaceuticals
Clinical trials sponsored by Biocryst Pharmaceuticals, explained in plain language.
-
New shot in the eye aims to halt diabetic vision loss
Disease control Recruiting nowThis is an early safety study testing a single experimental injection (avoralstat) into the eye for people with diabetic macular edema (DME), a cause of vision loss. The main goal is to see if the injection is safe and tolerable. Researchers will also look for early signs that it…
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First test of new drug for rare, severe skin disorder begins
Disease control Recruiting nowThis is the first study in people of an experimental drug called BCX17725 for Netherton Syndrome, a rare and serious genetic skin condition. The main goal is to check the drug's safety, how the body processes it, and the right dose. It will first test single and multiple doses in…
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC